Praxis Precision Medicines, Inc. — Investor Relations & Filings
Filings indexed
458
across all filing types
Latest filing
2026-06-01
Regulatory Filings
Country
US
United States of America
Listing
US
PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-01 | English | |
| 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-13 | English | |
| 10-Q - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-07 | English | |
| 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-04-14 | English | |
| 10-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | |
| 8-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923543 | 8-K | 2026-06-01 | English | ||
| 45762232 | 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-13 | English | ||
| 42975659 | 10-Q - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-05-07 | English | ||
| 34526963 | 8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer) | 2026-04-14 | English | ||
| 32896674 | 10-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | ||
| 32896673 | 8-K - PRAXIS PRECISION MEDICINES, INC. (0001689548) (Filer) | 2026-02-19 | English | ||
| 31313944 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31313940 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31313924 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31313936 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 31313941 | 4 Filing | 2026-02-10 | English | ||
| 31313927 | 4 Filing | 2026-02-10 | English | ||
| 31313942 | SCHEDULE 13G Filing | 2026-02-05 | English | ||
| 12992957 | FORM 4 | 2026-01-14 | English | ||
| 12992959 | FORM 4 | 2026-01-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biocon Ltd.
Develops biosimilars and novel biologics for diabetes, onco…
|
BIOCON | IN | Manufacturing |
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
Praxis Precision Medicines, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32153/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32153 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32153 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32153 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32153}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Praxis Precision Medicines, Inc. (id: 32153)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.